Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 4;13(1):124-127.
doi: 10.1159/000521785. eCollection 2022 Jan-Apr.

Uveitis after COVID-19 Vaccination

Je Hyung Hwang  1
Affiliations
Case Reports

Uveitis after COVID-19 Vaccination

Je Hyung Hwang. Case Rep Ophthalmol. .

Abstract

This report describes a case of acute uveitis following COVID-19 vaccination. A 21-year-old patient was referred to our department for decreased visual acuity and injection of the left eye. Two days prior, the patient received her second dose of the severe acute respiratory syndrome coronavirus 2 vaccine (BNT162b2, Pfizer-BioNTech). On ocular examination, her left eye's best-corrected visual acuity was 20/250, and its intraocular pressure was 16 mm Hg on a noncontact tonometer. Hypopyon, 4+ cells, and flares were observed in the anterior chamber. The patient was diagnosed with acute uveitis. She received topical dexamethasone (0.1%) hourly and systemic prednisone (50 mg/day). After 7 days, her inflammatory symptoms were mostly resolved. COVID-19 vaccination can cause acute anterior uveitis, which is responsive to steroids.

Keywords: COVID-19; Uveitis; Vaccination.

PubMed Disclaimer

Conflict of interest statement

We have no conflict of interest to declare.

Figures

Fig. 1
Fig. 1
Slit-lamp image at the initial visit.
Fig. 2
Fig. 2
Slit-lamp image on day 7 posttreatment.
See this image and copyright information in PMC

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang BMS, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb;382((8)):727–733. - PMC - PubMed
    1. Aslam S, Goldstein DR, Vos R, Gelman AE, Kittleson MM, Wolfe C, et al. COVID-19 vaccination in our transplant recipients: the time is now. J Heart Lung Transplant. 2021 Mar;40((3)):169–171. - PMC - PubMed
    1. Cook TM, Roberts JV. Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19. Anaesthesia. 2021 May;76((5)):608–616. - PMC - PubMed
    1. Chang JC, Hawley HB. Vaccine-associated thrombocytopenia and thrombosis: Venous endotheliopathy leading to venous combined micro-macrothrombosis. Medicina. 2021 Nov;5757((1111)):1163. - PMC - PubMed
    1. Phylactou M, Li JO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with sars-cov-2 messenger RNA vaccine. Br J Ophthalmol. 2021 Apr;105((7)):893–896. - PubMed

Publication types